RT Generic
T1 Is Irritable Bowel Syndrome Considered as Comorbidity in Clinical Trials of Physical Therapy Interventions in Fibromyalgia? A Scoping Review
A1 Rodriguez-Castillejo, Paula Ma
A1 Fernandez-de-las-Penas, Cesar
A1 Alburquerque-Sendin, Francisco
A1 Rodrigues-de-Souza, Daiana P.
K1 fibromyalgia
K1 irritable bowel syndrome
K1 clinical trials
K1 physiotherapy
K1 eligibility criteria
K1 Quality-of-life
K1 Randomized controlled-trial
K1 Cognitive-behavioral therapy
K1 Aerobic exercise
K1 High-risk
K1 Temporomandibular disorder
K1 General-population
K1 Rheumatology 1990
K1 Body-composition
K1 Self-management
AB Evidence supports the presence of comorbid conditions, e.g., irritable bowel syndrome (IBS), in individuals with fibromyalgia (FM). Physical therapy plays an essential role in the treatment of FM; however, it is not currently known whether the IBS comorbidity is considered in the selection criteria for clinical trials evaluating physiotherapy in FM. Thus, the aim of the review was to identify whether the presence of IBS was considered in the selection criteria for study subjects for those clinical trials that have been highly cited or published in the high-impact journals investigating the effects of physical therapy in FM. A literature search in the Web of Science database for clinical trials that were highly cited or published in high-impact journals, i.e., first second quartile (Q1) of any category of the Journal Citation Report (JCR), investigating the effects of physical therapy in FM was conducted. The methodological quality of the selected trials was assessed with the Physiotherapy Evidence Database (PEDro) scale. Authors, affiliations, number of citations, objectives, sex/gender, age, and eligibility criteria of each article were extracted and analyzed independently by two authors. From a total of the 412 identified articles, 20 and 61 clinical trials were included according to the citation criterion or JCR criterion, respectively. The PEDro score ranged from 2 to 8 (mean: 5.9, SD: 0.1). The comorbidity between FM and IBS was not considered within the eligibility criteria of the participants in any of the clinical trials. The improvement of the eligibility criteria is required in clinical trials on physical therapy that include FM patients to avoid selection bias.
PB Mdpi
YR 2021
FD 2021-10-01
LK https://hdl.handle.net/10668/28215
UL https://hdl.handle.net/10668/28215
LA en
DS RISalud
RD Apr 5, 2025